Paul Schimmel Overview

  • Investor Type
  • Angel

  • Investments
  • 1

  • Exits
  • 1


Paul Schimmel General Information


Mr. Paul Schimmel serves as Board Member at aTyr Pharma. He, Ph.D. has served as a director since September 2005. He is currently a director of Alnylam Pharmaceuticals, Inc. (Alnylam), a biopharmaceutical company (from which he is retiring at Alnylam's 2020 Annual Meeting of Stockholders), as well as a director of several private companies. He serves as Scientific Advisor & Board Member at Tevard Biosciences. He co-founded and served as a Member of the Scientific Advisory Board at Metabolon. He was a co-founder of Repligen Corporation, Alkermes, Inc. He served as Board Member at Kindex. Cubist Pharmaceuticals, Sirtris Pharmaceuticals, and Alnylam, and a founding Director of Momenta, Inc. He is Ernest and Jean Hahn Professor of Molecular Medicine and of Chemistry at Scripps Research. He also serves as an Advisor & Venture Partner at Cardinal Partners. He was formerly the John D. and Catherine T. MacArthur Professor of Biochemistry and Biophysics in the Department of Biology at the Massachusetts Institute of Technology. He holds a B.A. from Ohio Wesleyan University and a Ph.D. in biochemistry and biophysics from the Massachusetts Institute of Technology. He is an elected member of the National Academy of Sciences, the National Academy of Medicine, the National Academy of Inventors, the American Philosophical Society, and the American Academy of Arts and Sciences.

Contact Information

Primary Investor Type
Angel (individual)
Primary Office
  • 3545 John Hopkins Court
  • Suite 250
  • San Diego, CA 92121
  • United States
+1 (858) 000-0000

Paul Schimmel Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
000000 06-Mar-2015 00000 00000 00.00 Pharmaceuticals Out of Business 0000 00000000 00.0

Paul Schimmel Exits (1)

Company Name Exit Date Exit Type Exit Size
000000 02-Jul-2021 000 00 00000000

Paul Schimmel Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Paul Schimmel Team (1)

Name Title Deals Funds Boards Office
Paul Schimmel Ph.D Angel Investor 0 0 San Diego, CA